Influence of genotype, viral load and fibrosis on the sustained virologic response rate to pegylated interferon alpha-2a plus ribavirin, with or without amantadine, in chronic hepatitis C patients non-responders to alpha interferferon plus ribavirin

被引:0
|
作者
Cheinquer, H.
Pessoa, M.
Sette, H., Jr.
Parise, E.
Parana, R.
Tatsch, F.
机构
[1] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[2] Hosp Emilio Ribas, Sao Paulo, Brazil
[3] Pro Figado, Gastroenterol & Hepatol, Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Sao Paulo, Brazil
[5] Univ Fed Bahia, Salvador, BA, Brazil
[6] Roche, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
下载
收藏
页码:S147 / S147
页数:1
相关论文
共 50 条
  • [31] Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues
    Yu, Ming-Lung
    Dai, Chia-Yen
    Huang, Jee-Fu
    Hsieh, Ming-Yen
    Chuang, Wan-Long
    HEPATOLOGY, 2008, 47 (05) : 1792 - 1793
  • [32] High ribavirin dose and extended treatment can raise sustained virologic response in chronic hepatitis C genotype 1 patients treated with simeprevir, pegylated interferon plus ribavirin
    Tahata, Yuki
    Hiramatsu, Naoki
    Oze, Tsugiko
    Urabe, Ayako
    Morishita, Naoki
    Yamada, Ryoko
    Yakushijin, Takayuki
    Saji, Yukiko
    Doi, Yoshinori
    Hagiwara, Hideki
    Kaneko, Akira
    Fukui, Hiroyuki
    Inada, Masami
    Katayama, Kazuhiro
    Inoue, Atsuo
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY, 2015, 62 : 804A - 804A
  • [33] A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
    Muhammad Idrees
    Sheikh Riazuddin
    BMC Gastroenterology, 9
  • [34] Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin
    Bonardi, Renato
    Tabone, Marco
    Manca, Aldo
    Pellicano, Rinaldo
    Ciancio, Alessia
    Rizzetto, Mario
    BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (04) : 303 - 306
  • [35] Comparision of the Side Effects Due To Interferon Alpha 2A Plus Ribavirin and Pegylated Interferon Alpha 2A Plus Ribavirin Combinations For Chronic Hepatitis C Infection
    Ural, Onur
    Demir, Nazlim Aktug
    Sumer, Sua
    Ural, Gaye
    Balci, Mehmet
    TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2010, 27 (03): : 261 - 264
  • [36] Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy
    Moreno-Monteagudo, JA
    Fernandez-Bermejo, M
    Garcia-Buey, L
    Sanz, P
    Iacono, LO
    Garcia-Monzon, C
    Borque, MJ
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 717 - 723
  • [37] Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C
    Teuber, G
    Berg, T
    Hoffmann, RM
    Leifeld, L
    Lafrenz, M
    Spengler, U
    Pape, GR
    Hopf, U
    Zeuzem, S
    DIGESTION, 2000, 61 (02) : 90 - 97
  • [38] Efficacy of pegylated interferon alpha-2b in combination with ribavirin in patients with chronic hepatitis C non-responders to a previous treatment
    Chousterman, M
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    JOURNAL OF HEPATOLOGY, 2003, 38 : 133 - 134
  • [39] Combination therapy with interferon alfa-2b, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin
    Pande, H
    Thuluvath, PJ
    Jaffer, SA
    Maygers, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S96 - S96
  • [40] VITAMIN D DEFICIENCY AND SUSTAINED VIROLOGIC RESPONSE ON ANTIVIRAL THERAPY WITH PEGYLATED INTERFERON ALPHA 2 AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C, GENOTYPE-1
    Kukhareva, Elena
    Tarasova, Olga
    Ogurtsov, Pavel
    GASTROENTEROLOGY, 2019, 156 (06) : S1344 - S1344